INOZYME PHARMA, INC. Interest Expense
INOZYME PHARMA, INC. reported Interest Expense of $1.40 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-06
- INOZYME PHARMA, INC. interest expense for the quarter ending 2024-06-30 was $1.40M, a 80.93% increase year-over-year.
- INOZYME PHARMA, INC. interest expense for the quarter ending 2024-03-31 was $1.32M, a 303.96% increase year-over-year.
- INOZYME PHARMA, INC. interest expense for the quarter ending 2023-06-30 was $771.00K.
- INOZYME PHARMA, INC. interest expense for the quarter ending 2023-03-31 was $328.00K.
- INOZYME PHARMA, INC. interest expense for fiscal 2023 was $3.33M, a 1172.14% increase from fiscal 2022.
- INOZYME PHARMA, INC. interest expense for fiscal 2022 was $262.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 12 month |
|---|---|---|---|
| 2024-06-30 | $1.40M 10-Q · filed 2024-08-06 | $2.72M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-07 | ||
| 2023-12-31 | $3.33M 10-K · filed 2024-03-12 | ||
| 2023-06-30 | $771.00K 10-Q · filed 2024-08-06 | $1.10M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | $328.00K 10-Q · filed 2024-05-07 | ||
| 2022-12-31 | $262.00K 10-K · filed 2024-03-12 |